84-2804-79 [取扱停止]DAP Kinase 1, CT (Death-associated Protein Kinase 1, DAPK1, DAPK) (MaxLight 490) 100ul D1051-01A-ML490
特徴
MaxLight™490 is a new Blue-Green photostable dye conjugate comparable to DyLight™488, Alexa Fluor™488 and offers better labeling efficiency, brighter imaging and increased immunodetection.
Absorbance (491nm); Emission (515nm); Extinction Coefficient 73,000.
Death-associated protein kinase 1 is a positive mediator of gamma-interferon induced programmed cell death (apoptosis).
DAPK1 encodes a structurally unique 160-kD calmodulin dependent serine-threonine kinase that carries 8 ankyrin repeats and 2 putative P-loop consensus sites.
It is a tumor suppressor candidate.
Applications:Suitable for use in FLISA, Western Blot, and Immunohistochemistry.
Other applications not tested.
Recommended Dilution:FLISA: 1:1,000Western Blot: 1:100-1:500Immunohistochemistry: 1:50-1:100Optimal dilutions to be determined by the researcher.
Storage and Stability:Store product at 4°C in the dark.
DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
Dilute required amount only prior to immediate use.
Further dilutions can be made in assay buffer.
Caution: MaxLight™490 conjugates are sensitive to light.
For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Note: Applications are based on unconjugated antibody.
仕様
Size:100ul
Host:rabbit
Source Antibody:human
Grade:Affinity Purified
Purity:Purified by Protein G affinity chromatography.
Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™490.
Specificity:Recognizes human DAPK1. Species Crossreactivity: mouse.
Isotype:IgG
Calc Applications Abbrev:FLISA IHC WB
Calc Crossreactivity:Hu Mo
Immunogen:Synthetic peptide selected from the C-terminal region of human DAPK1 (KLH).
Shelf Life:1year
Swiss Prot Number:P53355
EU Commodity Code:30021010
この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
【試薬に関するお問合せ】
アズワン株式会社 試薬・プロセス材料グループ
TEL:06-6447-8641
FAX:06-6447-8642
E-mail:[email protected]